<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (BD) is a <z:hpo ids='HP_0011010'>chronic</z:hpo>, relapsing <z:hpo ids='HP_0002633'>vasculitis</z:hpo> of unknown etiology </plain></SENT>
<SENT sid="1" pm="."><plain>Its association with <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) is extremely rare, and typical manifestations of BD were observed in a very few patients with <z:mp ids='MP_0005481'>CML</z:mp>, mainly under interferon-alpha (IFN-alpha) treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Skin <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> test, being positive in about 50% of patients with BD, is also positive in some IFN-alpha-treated patients with <z:mp ids='MP_0005481'>CML</z:mp> without any evidence of BD symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>We describe a 62-year-old woman with <z:mp ids='MP_0005481'>CML</z:mp> who developed characteristic features of BD, including a positive skin <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> test, during treatment with <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="44423">Hydroxyurea</z:chebi> has been implicated in the appearance of skin vasculitic ulceration, but this is the first case, according to our knowledge, where the development of BD was observed during <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> maintenance in the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase of <z:mp ids='MP_0005481'>CML</z:mp> </plain></SENT>
</text></document>